Australia injects $18 M into novel CAR-T cell therapy

Singapore, July 21 -- A "precision guided" CAR T-cell therapy designed at Peter MacCallum Cancer Centre, Australia's only public health service dedicated to caring for people affected by cancer, to ki... Read More

Singapore develops swallowable nanocage for targeted gastric cancer therapy

Singapore, July 21 -- Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have developed a swallowable nanoscale delivery platform designed to transp... Read More

Fangzhou launches Novo Nordisk's once-weekly basal insulin/GLP-1 therapy in China

Singapore, July 21 -- Fangzhou Inc. has announced the launch of Kyinsu(R), the world's first once-weekly basal insulin/GLP-1 RA combination therapy, on its Internet hospital platform, further expandin... Read More

Japanese startup Rege Nephro secures $10.6 M to expand kidney disease pipeline

Singapore, July 21 -- Rege Nephro, a clinical-stage biotechnology startup focused on induced pluripotent stem (iPS) cell-based kidney regenerative medicine and drug discovery, has announced the closin... Read More

Menarini and Pharmacosmos bring first-in-class oncology supportive care therapy Cosela(R) to Asia

Singapore, July 21 -- Menarini Asia-Pacific has announced an exclusive partnership with Pharmacosmos A/S to register, commercialise and distribute Cosela(R) (trilaciclib) across its Asia-Pacific marke... Read More

Korea's Samsung Biologics buys PolyPeptide for CHF 1.46 B

Singapore, July 20 -- South Korea-based Samsung Biologics has announced the launch of an all-cash public tender offer to acquire 100% of the fully diluted share capital of PolyPeptide Group AG, a lead... Read More

AstraZeneca inks $1.5 B deal with China's Dizal Pharma for novel oral EGFR inhibitor Zegfrovy for lung cancer

Singapore, July 20 -- AstraZeneca has entered into an exclusive license agreement with China-based Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel oral irreversible epidermal growth factor ... Read More

Galderma launches Alastin(R) in Japan and key markets across Asia Pacific

Singapore, July 20 -- Galderma has announced the launch of Alastin - its premium regenerative skincare brand - across the JPAC region. The brand recently launched in Taiwan, will soon launch in Japan,... Read More

Merck invests €25 M in BioReliance(R) testing facility to support drug product release in Europe

Singapore, July 20 -- Merck, a leading science and technology company, has opened a new €25 million BioReliance(R) testing facility at its global headquarters in Darmstadt, Germany. The facility... Read More

Cordex expands Zemcelpro access to Hong Kong and Singapore for stem cell transplantation

Singapore, July 17 -- Canada-based ExCellThera Inc., a global leader in blood stem cell expansion and metabolic fitness technologies and parent company of Cordex Biologics, has announced that Cordex h... Read More

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»